Easywell Biomedicals, Inc. (TPEX:1799)

Easywell Biomedicals Revenue

Easywell Biomedicals had revenue of 190.47M TWD in the quarter ending September 30, 2024, with 179.48% growth. This brings the company's revenue in the last twelve months to 483.81M, up 100.39% year-over-year. In the year 2023, Easywell Biomedicals had annual revenue of 271.63M with 51.83% growth.

• Revenue (ttm): 483.81M
• Revenue Growth: +100.39%
• P/S Ratio: 16.61
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	271.63M	92.73M	51.83%
Dec 31, 2022	178.90M	-18.38M	-9.32%
Dec 31, 2021	197.28M	-70.38M	-26.29%
Dec 31, 2020	267.65M	-92.31M	-25.64%
Dec 31, 2019	359.96M	-59.22M	-14.13%